Voyager Therapeutics Inc (VYGR)
SBC to Revenue
76.87%
Quarterly · Period ending:
VYGR SBC to Revenue
Latest reported76.87%period ending
Latest reported76.87%period ending
VYGR Quarterly SBC/Revenue (0.00% → 76.87%)
Latest values, visible window
High-resolution chart · PNG
VYGR sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 76.872% | |
| 95.9506% | |
| 22.9591% | |
| 25.8885% | |
| 79.4808% | |
| 56.7434% | |
| 59.5253% | |
| 13.9389% | |
| 13.6656% | |
| 18.3081% | |
| 3.381% | |
| 62.3754% | |
| 55.0587% | |
| 1.6999% | |
| -151.3548% | |
| 5.3278% | |
| 349.7191% | |
| 352.4316% | |
| 5.8918% | |
| 140.2159% | |
| 294.1046% | |
| 55.3915% | |
| 0% | |
| 0% | |
| 13.4584% | |
| 22.3612% | |
| 0% | |
| 16.3902% | |
| 11.398% | |
| 67.6929% | |
| 131.3745% | |
| 125.8835% | |
| 315.1068% | |
| 246.4968% | |
| 36.1387% | |
| 282.3171% | |
| 130.7562% | |
| 147.8825% | |
| 75.4445% | |
| 54.081% | |
| 35.4032% | |
| 29.441% | |
| 39.8218% | |
| 17.3587% | |
| 18.4685% | |
| 11.7236% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |